Envoy Medical (COCH) Research & Development (2022 - 2026)
Envoy Medical (COCH) posted Research & Development of $3.6 million for Q1 2026, down 20.01% sequentially from $4.6 million in Q4 2025, and up 32.53% YoY from $2.7 million in Q1 2025.
Envoy Medical (COCH) Research & Development (2022 - 2026) Analysis & Trends
Envoy Medical has reported Research & Development for 5 years, with the latest figure at $3.6 million in Q1 2026.
- Quarterly Research & Development rose 32.53% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (up 166.66% YoY) and the FY2025 annual result came in at $12.5 million, up 620.07% from the prior year.
- Research & Development slipped to $3.6 million in Q1 2026 per COCH's latest filing, from $4.6 million in the prior quarter.
- Over five years, Research & Development peaked at $4.6 million in Q4 2025 and troughed at -$4.2 million in Q4 2023.
- A 5-year average of $718200.0 and a median of $405000.0 in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2025: Research & Development plunged 59.99% in 2023, then soared 778.96% in 2025.
- Over 5 years, Research & Development stood at -$2.6 million in 2022, then sank by 59.99% to -$4.2 million in 2023, then surged by 112.23% to $518000.0 in 2024, then jumped by 778.96% to $4.6 million in 2025, then retreated by 20.01% to $3.6 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $3.6 million, $4.6 million, and $405000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Envoy Medical | 76.96 Mn | 57.28 Mn | -227,000.00 | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.13 Mn |
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 4.55 Mn |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.75 Mn |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 394,000.00 |
| Jun 30, 2024 | 497,000.00 |
| Mar 31, 2024 | 325,000.00 |
| Dec 31, 2023 | -4.24 Mn |
| Sep 30, 2023 | 399,000.00 |
| Jun 30, 2023 | 383,000.00 |
| Mar 31, 2023 | 371,000.00 |
| Dec 31, 2022 | -2.65 Mn |
| Sep 30, 2022 | 935,000.00 |